Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 1,726 shares at $36.16 ($61K) on 2021-04-01, disclosed to the SEC on 2021-04-02.
Scheduled sale ($61k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.04 | 1,426 | $50K | 82.2% |
| 2 | $36.16 | 300 | $11K | 17.8% |
| Total | $35.23 avg | 1,726 | $61K | 100% |
| Filing → |
| ALBO | SELL | 2022-10-25 | $13K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $16K | — | Filing → |
| ALBO | SELL | 2022-04-25 | $22K | — | Filing → |